By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Argos Therapeutics, Inc. (Formerly Merix Bioscience) 

4233 Technology Drive

Durham  North Carolina  27704  U.S.A.
Phone: 919-287-6300 Fax: 919-287-6301


SEARCH JOBS


Industry
Biotechnology


Collaborations

Duke University  Exclusive license to the RNA based vaccine technology.

Rockefeller University  Exclusive worldwide rights to technology developed at Rockefeller relating to generation of dendritic cells.

Baylor University  Clinical and preclinical research in Lupus.

Kirin Brewery Co., Ltd.  The companies will collaborate to develop and commercialize dendritic cell vaccines, initially in the areas of cancer and infectious diseases.

Erlangen University  Clinical and preclinical research in Melanoma.





Company News
Argos Therapeutics, Inc. (ARGS) Announces Formation Of Scientific Advisory Board 7/21/2015 7:23:11 AM
10 Biotech Firms Rapidly Expanding in North Carolina 7/21/2015 5:01:57 AM
Argos Therapeutics, Inc. (ARGS) To Present At 8th IAS Conference On HIV Pathogenesis, Treatment And Prevention 7/17/2015 7:31:55 AM
Argos Therapeutics, Inc. (ARGS) Announces Completion Of Patient Enrollment In Pivotal Phase III ADAPT Clinical Trial Of AGS-003 7/15/2015 7:04:14 AM
Argos Therapeutics, Inc. (ARGS) To Present At The 2015 JMP Securities Life Sciences Conference 6/17/2015 1:11:23 PM
Argos Therapeutics, Inc. (ARGS) Hires John D. Menditto As Vice President Of Corporate Communications And Investor Relations 6/15/2015 7:57:04 AM
Argos Therapeutics, Inc. (ARGS) Release: Independent Data Monitoring Committee Recommends Continuation Of Pivotal ADAPT Phase III Clinical Trial Of AGS-003 For Metastatic Renal Cell Carcinoma 6/4/2015 7:42:31 AM
Argos Therapeutics, Inc. (ARGS) To Present At The Annual Sachs Immuno-Oncology: BD&L And Investment Forum 5/29/2015 1:19:39 PM
Argos Therapeutics, Inc. (ARGS) To Present At The World Stem Cells Regenerative Medicine Congress 2015 5/20/2015 2:07:09 PM
Argos Therapeutics, Inc. (ARGS) Reports First Quarter 2015 Financial Results And Operational Highlights 5/15/2015 8:35:52 AM
12345678910...
//-->